“Surgery Following Induction (Neoadjuvant) Therapy With Pembrolizumab in Lung Adenocarcinoma With High PD-L1 Expression”. 2025. Respirar 17 (1): 68-75. https://doi.org/10.55720/respirar.17.1.6.